Additional information
Pale yellow Powder
2518153-95-0
ACI-020813
75.0-76.2°C
C11H12BrN3
266.14
Ambient
2-8°C
ocular hypertension
Pharmaceutical Impurity Standards
N-propylamino-5-bromoquinoxaline
6-(2-imidazoline-2-ylidineamino)-1,2,3,4-tetrahydroquinoxalin-2,3-dione
2-Quinoxalinamine, 5-bromo-N-propyl





![sec-BUTYL PACLITAXEL (25 mg) ((2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-Bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl (αR,βS)-α-hydroxy-β-[[(2S)-2-methyl-1-oxobutyl]amino]benzenepropanoate)](https://analyticachemie.in/wp-content/uploads/uspimage-1.jpg)